Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC

Watchlist Manager
Cyclacel Pharmaceuticals Inc Logo
Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC
Watchlist
Price: 6.365 USD -5.98% Market Closed
Market Cap: 14.3m USD

Wall Street
Price Targets

CYCC Price Targets Summary
Cyclacel Pharmaceuticals Inc

There are no price targets for CYCC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Cyclacel Pharmaceuticals Inc Competitors:
Price Targets
CRSP
CRISPR Therapeutics AG
46% Upside
ATX
Amplia Therapeutics Ltd
243% Upside
IMMU
Mendus AB (publ)
227% Upside
300685
Amoy Diagnostics Co Ltd
43% Upside
CYTK
Cytokinetics Inc
32% Upside
PHARM
Pharming Group NV
45% Upside
SPRY
ARS Pharmaceuticals Inc
149% Upside
MIRM
Mirum Pharmaceuticals Inc
32% Upside

Revenue
Forecast

Revenue Estimate
Cyclacel Pharmaceuticals Inc

The compound annual growth rate of Cyclacel Pharmaceuticals Inc's revenue for the next 3 years is 1 141%.

N/A
Past Growth
1 141%
Estimated Growth
Estimates Accuracy
6%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Cyclacel Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Cyclacel Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CYCC's stock price target?
Not Available

CYCC doesn't have any price targets made by Wall Street professionals.

What is Cyclacel Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
1 141%

The compound annual growth rate of Cyclacel Pharmaceuticals Inc's revenue for the next 3 years is 1 141%.

Back to Top